63,615 Cardinal Health, Inc. $CAH Shares Acquired by International Assets Investment Management LLC

International Assets Investment Management LLC boosted its position in Cardinal Health, Inc. (NYSE:CAH) by 4,593.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 65,000 shares of the company’s stock after buying an additional 63,615 shares during the period. International Assets Investment Management LLC’s holdings in Cardinal Health were worth $14,462,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. BlackRock Inc. bought a new stake in shares of Cardinal Health during the 2nd quarter valued at about $6,293,115,000. Wellington Management Group LLP increased its holdings in Cardinal Health by 247.5% in the second quarter. Wellington Management Group LLP now owns 14,860,271 shares of the company’s stock worth $3,530,206,000 after purchasing an additional 10,584,119 shares in the last quarter. Bank of America Corp DE acquired a new position in Cardinal Health in the second quarter valued at approximately $689,066,000. Legal & General Group Plc acquired a new position in Cardinal Health in the second quarter valued at approximately $438,870,000. Finally, Pacer Advisors Inc. boosted its holdings in shares of Cardinal Health by 14.7% during the 1st quarter. Pacer Advisors Inc. now owns 1,565,131 shares of the company’s stock worth $330,728,000 after buying an additional 200,021 shares in the last quarter. Institutional investors own 87.17% of the company’s stock.

Insider Buying and Selling at Cardinal Health

In other news, CEO Stephen M. Mason sold 35,000 shares of the stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $236.40, for a total value of $8,274,000.00. Following the completion of the sale, the chief executive officer directly owned 18,061 shares of the company’s stock, valued at $4,269,620.40. This represents a 65.96% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Michelle D. Greene sold 11,650 shares of the firm’s stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $235.72, for a total value of $2,746,138.00. Following the completion of the transaction, the insider owned 10,330 shares in the company, valued at $2,434,987.60. This represents a 53.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 210,271 shares of company stock worth $49,626,657. 0.12% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on CAH. Wall Street Zen raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research report on Sunday, October 25th. Royal Bank Of Canada assumed coverage on Cardinal Health in a research note on Wednesday, August 19th. They set an “outperform” rating and a $276.00 price target on the stock. Mizuho increased their price target on Cardinal Health from $250.00 to $280.00 and gave the stock an “outperform” rating in a report on Tuesday, October 20th. Leerink Partners set a $292.00 price objective on Cardinal Health in a research note on Tuesday, August 11th. Finally, Wells Fargo & Company boosted their price objective on Cardinal Health from $245.00 to $277.00 and gave the company an “overweight” rating in a report on Wednesday, August 12th. Sixteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $270.69.

Cardinal Health Trading Down 0.3%

Cardinal Health stock opened at $250.41 on Friday. Cardinal Health, Inc. has a 1-year low of $180.45 and a 1-year high of $259.84. The firm has a market capitalization of $57.98 billion, a price-to-earnings ratio of 34.63, a price-to-earnings-growth ratio of 1.51 and a beta of 0.50. The firm’s fifty day moving average price is $237.74 and its two-hundred day moving average price is $222.29.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Tuesday, August 11th. The company reported $2.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.42 by $0.49. The firm had revenue of $63.67 billion during the quarter, compared to analysts’ expectations of $65.15 billion. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The business’s revenue was up 5.8% on a year-over-year basis. During the same period last year, the company earned $2.08 earnings per share. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. On average, research analysts forecast that Cardinal Health, Inc. will post 12.55 EPS for the current year.

Cardinal Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st were paid a dividend of $0.5158 per share. The ex-dividend date was Thursday, October 1st. This represents a $2.06 dividend on an annualized basis and a yield of 0.8%. Cardinal Health’s payout ratio is 28.49%.

Cardinal Health Profile

Cardinal Health, Inc is a healthcare services and products company that supports the distribution and delivery of pharmaceuticals, medical products and related services. The company serves hospitals, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.

Its Pharmaceutical and Specialty Solutions segment distributes branded, generic and specialty pharmaceuticals, as well as consumer health products, to pharmacies and healthcare institutions.